Efficacy and prognosis of transurethral holmium laser en-blocresection of bladder tumor in the treatment of non-invasive bladder cancer

Journal Title: Chinese Journal of Clinical Research - Year 2024, Vol 37, Issue 6

Abstract

Objective To investigate the efficacy and prognosis of transurethral holmium laser en-bloc resection of bladder tumor (HOLRBT) and transurethral resection of bladder tumor (TURBT) in the treatment of non-invasive bladder cancer. Methods Eighty-six patients with non-invasive bladder cancer treated in the Third Affiliated Hospital of Anhui Medical University from January 2019 to May 2021 were selected as the study subjects. According to the random number table method, they were divided into the observation group (treated with HOLRBT) and the control group (treated with TURBT), with 43 patients in each group. The following indexes were compared, including operation time, hospital stay, bleeding volume, bladder irrigation time, urinary catheter retention time, peripheral blood lymphocyte subsets(CD4+, CD8+, CD4+/CD8+), serum micro-RNA-119a (miR-119a), cytokeratin fragment antigen (CYFRA21-1), urine nuclear matrix protein 22 (NMP-22) levels, as well as the complications rates, recurrence rates and survival time. Results There was no statistically significant difference in operation time, hospital stay, and complication incidence between the two groups (P>0.05). The bleeding volume, bladder irrigation time, and urinary catheter retention time in the observation group were shorter than those in the control group (P<0.05). There was no statistically significant difference in preoperative CD4+, CD8+, CD4+/CD8+, miR-119a, CYFRA21-A and NMP-22 (P>0.05). Three days after surgery, levels of CD4+ and CD4+/CD8+ in the observation group were higher than those in the control group, while levels of CD8+, miR-119a, CYFRA21-A, and NMP-22 were lower than those in the control group (P<0.05). During the follow-up to June 2023, the 1-year and 2-year postoperative recurrence rates in the observation group were lower than those in the control group, while the progression-free survival time was longer than that in the control group (P<0.05). Conclusion HOLRBT has an ideal effect in the treatment of non-invasive bladder cancer, which is conducive to prolonging the postoperative progression-free survival time and reducing the recurrence rate of patients.

Authors and Affiliations

SUN Cheng, ZHANG Chao, LI Qinghua, WANG Yu, WEN Zhu, YANG Shuai

Keywords

Related Articles

Therapeutic effects of two types of interbody fusions on degenerative lumbar spondylolisthesis in the elderly based on spinal pelvic anatomy and lumbar spondylolisthesis mechanics

<b>Objective</b> To evaluate the therapeutic effects of oblique lateral interbody fusion (OLIF) and minimally invasive transforminal lumbar interbody fusion (MIS-TLIF) on degenerative lumbar spondylolisthesis (DLS) in t...

Research progress on the mechanism of action of gut microbiota on hepatocellular carcinoma

Hepatocellular carcinoma (HCC) has a high incidence rate among the malignant tumors reported in the world, and its incidence rate and mortality continue to rise. In recent years, researches have shown that the gut microb...

Expression and clinical significance of tumor necrosis factor receptor superfamily 4 in laryngeal squamous cell carcinoma

<b>Objective</b> To analyze the changes in tumor necrosis factor receptor superfamily (TNFRSF) 4 expression levels in laryngeal squamous cell carcinoma (LSCC) patients through multiple database data combined with clinic...

Effects of laparoscopic surgery combined with hyperthermic intraperitoneal chemotherapy on postoperative coagulation indicators in patients with colorectal cancer

Objective To observe the changes of coagulation function in patients with colorectal cancer (CRC) after laparoscopic surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC). Methods Sixty patients with CR...

Research progress of esketamine and postoperative delirium

Postoperative delirium (POD) is a common complication in elderly patients after surgery, significantly affecting prognosis and increasing mortality rates. The underlying mechanisms of POD remain unclear, with diverse ris...

Download PDF file
  • EP ID EP738421
  • DOI 10.13429/j.cnki.cjcr.2024.06.018
  • Views 43
  • Downloads 0

How To Cite

SUN Cheng, ZHANG Chao, LI Qinghua, WANG Yu, WEN Zhu, YANG Shuai (2024). Efficacy and prognosis of transurethral holmium laser en-blocresection of bladder tumor in the treatment of non-invasive bladder cancer. Chinese Journal of Clinical Research, 37(6), -. https://europub.co.uk/articles/-A-738421